1 04, 2023 Shooting Cancer Highlights – Monthly focus on regulatory status of new targeted therapies in oncology – February and March 2023 adlitterio663392023-06-28T10:51:22+02:00 Read More
15 11, 2022 Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – October 2022 adlitterio663392023-04-06T11:41:01+02:00 Read More
15 03, 2022 Giuseppe Lippi et al., Fujirebio Lumipulse SARS-CoV-2 antigen immunoassay: pooled analysis of diagnostic accuracyc adlitterio663392022-10-20T12:34:22+02:00 Read More
31 10, 2018 M Kursat Evrenos et. al, Clinicopathological characteristics and mutation profile of BRAF and NRAS mutation in cutaneous melanomas in the Western Turkish population Diatech Pharmacogenetics2018-12-04T14:23:43+01:00 Read More
4 12, 2017 G Aggarwal et. al, SOX2 Immunoexpression in High-Grade Gliomas: Potential Marker for Targeted Therapy Diatech Pharmacogenetics2022-02-23T12:55:34+01:00 Read More
2 11, 2017 Giulia Morosetti et al., Ellagic acid and Annona muricata in the chemoprevention of HPV-related pre-neoplastic lesions of the cervix. Diatech Pharmacogenetics2017-11-02T12:39:23+01:00 Read More
31 10, 2017 Maria R. Ambrosio et. al, MicroRNAs sequencing unveils distinct molecular subgroups of plasmablastic lymphoma Diatech Pharmacogenetics2017-12-12T17:41:30+01:00 Read More
2 10, 2017 Graziella Pinotti et al.,1335PEGFR T790M detection in TKI-naïve NSCLCs carrying sensitive EGFR mutations Diatech Pharmacogenetics2017-10-02T14:44:48+02:00 Read More
